CORRESP Filing
IO Biotech, Inc.
Date: July 29, 2025 · CIK: 0001865494 · Accession: 0001193125-25-168423
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288936
Letter
Re:
IO Biotech, Inc. Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark July 29, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720
Attention:
Alan Campbell
IO Biotech, Inc. Registration Statement on Form S-3, as amended File No. 333-288936
Acceleration Request
Requested Date: July 31, 2025
Requested Time: 4:00 P.M., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, IO Biotech, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3, as amended (the “ Registration Statement ”), be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on July 31, 2025, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Please contact Nick DeAngelis of Sidley Austin LLP at (214) 969-3563 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
Very truly yours,
/s/ Devin Smith
Show Raw Text
CORRESP 1 filename1.htm CORRESP IO Biotech, Inc. Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark July 29, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Alan Campbell Re: IO Biotech, Inc. Registration Statement on Form S-3, as amended File No. 333-288936 Acceleration Request Requested Date: July 31, 2025 Requested Time: 4:00 P.M., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, IO Biotech, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3, as amended (the “ Registration Statement ”), be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on July 31, 2025, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Please contact Nick DeAngelis of Sidley Austin LLP at (214) 969-3563 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement. Very truly yours, /s/ Devin Smith Devin Smith General Counsel IO Biotech, Inc. cc: Mai-Britt Zocca, IO Biotech, Inc. Amy Sullivan, IO Biotech, Inc. Frank Rahmani, Sidley Austin LLP Istvan Hajdu, Sidley Austin LLP Nick DeAngelis, Sidley Austin LLP